Piper Sandler Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice TargetHot
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $92 to $96.
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $92 to $96.